Sign in
4

Changes in Ownership

RECURSION PHARMACEUTICALS, INC. Filed Acc 0001209191-23-046423

Chief Financial Officer sold 50,000 shares at an average $9.09 ($454,310)

  • Chief Financial Officer acquired 75,000 shares (option exercise)
  • Chief Financial Officer gave up 4,727 shares (to pay taxes)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Secora Michael · Chief Financial Officer

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2023-08-15 Shares withheld for taxes : show line 1 in the form 10b5-1 −4,727 $9.19 $43,441 838,186 D
2023-08-15 Exercise or conversion : show line 2 in the form 10b5-1 +37,500 $2.22 $83,250 875,686 D
2023-08-15 Sale : show line 3 in the form 10b5-1 −25,000 $9.27 $231,793 850,686 D
2023-08-16 Exercise or conversion : show line 4 in the form 10b5-1 +37,500 $2.22 $83,250 888,186 D
2023-08-16 Sale : show line 5 in the form 10b5-1 −25,000 $8.90 $222,518 863,186 D
Open-market sales · 50,000 sh · avg $9.09 · $454,310

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2023-08-15 Exercise or conversion : show line 6 in the form 10b5-1 Stock Option (Right to Buy) −37,500 $2.22 2030-03-03 37,500 1,485,135 D
2023-08-16 Exercise or conversion : show line 7 in the form 10b5-1 Stock Option (Right to Buy) −37,500 $2.22 2030-03-03 37,500 1,410,135 D
Loading xslF345X05/doc4.xml…